Darcy Mootz

Direttore/Membro del Consiglio presso ELEVATION ONCOLOGY, INC.

Patrimonio netto: - $ in data 30/04/2024

Health Technology

Consumer Services

Profilo

Darcy Mootz is an Independent Director at Elevation Oncology, Inc. She previously worked as a Senior Director of Corporate Development at Achaogen, Inc. and as a Chief Business Officer at Oric Pharmaceuticals, Inc. Mootz received her undergraduate degree from Duke University and her doctorate from Harvard University.

Partecipazioni note in società pubbliche

Società	Data	Numero di azioni	Valorizzazione	Data di valutazione
ELEVATION ONCOLOGY, INC. -.--%	31/03/2024	0 ( -.--% )	- $	30/04/2024

Posizioni attive di Darcy Mootz

Società	Posizione	Inizio
ELEVATION ONCOLOGY, INC.	Direttore/Membro del Consiglio	18/01/2024

Tutte le posizioni attive di Darcy Mootz

Precedenti posizioni note di Darcy Mootz

Società	Posizione	Fine
ORIC PHARMACEUTICALS, INC.	Corporate Officer/Principal	-
ACHAOGEN	Corporate Officer/Principal	-

Vedi nel dettaglio l'esperienza di Darcy Mootz

Formazione di Darcy Mootz

Harvard University	Doctorate Degree
Duke University	Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Darcy Mootz

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	2
ORIC PHARMACEUTICALS, INC.	Health Technology
ELEVATION ONCOLOGY, INC.	Health Technology

Aziende private	1
Achaogen, Inc. Achaogen, Inc. Pharmaceuticals: MajorHealth Technology Achaogen, Inc. engages in developing and commercializing innovative antibacterial agents for multi-drug resistant gram-negative infections. The firm is also involved in the development of C-Scape, an orally administered antibiotic to address a serious unmet need for an effective oral treatment for patients with complicated urinary tract infections, including pyelonephritis caused by extended spectrum beta-lactamases producing Enterobacteriaceae. The company was founded by Nathaniel Eames David, Floyd E. Romesberg, and Peter G. Schultz in June 2002 and is headquartered in South San Francisco, CA.	Health Technology